Literature DB >> 17311285

Transgenic mice expressing LHX3 transcription factor isoforms in the pituitary: effects on the gonadotrope axis and sex-specific reproductive disease.

Jesse J Savage1, Rachel D Mullen, Kyle W Sloop, Stephanie C Colvin, Sally A Camper, Craig L Franklin, Simon J Rhodes.   

Abstract

The LHX3 transcription factor plays critical roles in pituitary and nervous system development. Mutations in the human LHX3 gene cause severe hormone deficiency diseases. The gene produces two mRNAs which can be translated to three protein isoforms. The LHX3a protein contains a central region with LIM domains and a homeodomain, and a carboxyl terminus with the major transactivation domain. LHX3b is identical to LHX3a except that it has a different amino terminus. M2-LHX3 lacks the amino terminus and LIM domains of LHX3a/b. In vitro experiments have demonstrated these three proteins have different biochemical and gene regulatory properties. Here, to investigate the effects of overexpression of LHX3 in vivo, the alpha glycoprotein subunit (alphaGSU) promoter was used to produce LHX3a, LHX3b, and M2-LHX3 in the pituitary glands of transgenic mice. Alpha GSU-beta galactosidase animals were generated as controls. Male alphaGSU-LHX3a and alphaGSU-LHX3b mice are infertile and die at a young age as a result of complications associated with obstructive uropathy including uremia. These animals have a reduced number of pituitary gonadotrope cells, low circulating gonadotropins, and possible sex hormone imbalance. Female alphaGSU-LHX3a and alphaGSU-LHX3b transgenic mice are viable but have reduced fertility. By contrast, alphaGSU-M2-LHX3 mice and control mice expressing beta galactosidase are reproductively unaffected. These overexpression studies provide insights into the properties of LHX3 during pituitary development and highlight the importance of this factor in reproductive physiology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17311285     DOI: 10.1002/jcp.21010

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

1.  Heterozygous LHX3 mutations may lead to a mild phenotype of combined pituitary hormone deficiency.

Authors:  Nicolas Jullien; Pauline Romanet; Mélanie Philippon; Marie-Hélène Quentien; Paolo Beck-Peccoz; Ignacio Bergada; Sylvie Odent; Rachel Reynaud; Anne Barlier; Alexandru Saveanu; Thierry Brue; Frederic Castinetti
Journal:  Eur J Hum Genet       Date:  2018-09-27       Impact factor: 4.246

2.  Rescue of obesity-induced infertility in female mice due to a pituitary-specific knockout of the insulin receptor.

Authors:  Kathryn J Brothers; Sheng Wu; Sara A DiVall; Marcus R Messmer; C Ronald Kahn; Ryan S Miller; Sally Radovick; Fredric E Wondisford; Andrew Wolfe
Journal:  Cell Metab       Date:  2010-09-08       Impact factor: 27.287

3.  A distal modular enhancer complex acts to control pituitary- and nervous system-specific expression of the LHX3 regulatory gene.

Authors:  Rachel D Mullen; Soyoung Park; Simon J Rhodes
Journal:  Mol Endocrinol       Date:  2011-12-22

4.  Model of pediatric pituitary hormone deficiency separates the endocrine and neural functions of the LHX3 transcription factor in vivo.

Authors:  Stephanie C Colvin; Raleigh E Malik; Aaron D Showalter; Kyle W Sloop; Simon J Rhodes
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-13       Impact factor: 11.205

5.  Three novel missense mutations within the LHX4 gene are associated with variable pituitary hormone deficiencies.

Authors:  Roland W Pfaeffle; Chad S Hunter; Jesse J Savage; Mario Duran-Prado; Rachel D Mullen; Zachary P Neeb; Urs Eiholzer; Volker Hesse; Nadine G Haddad; Heike M Stobbe; Werner F Blum; Johannes F W Weigel; Simon J Rhodes
Journal:  J Clin Endocrinol Metab       Date:  2007-12-11       Impact factor: 5.958

6.  Cell-specific actions of a human LHX3 gene enhancer during pituitary and spinal cord development.

Authors:  Soyoung Park; Rachel D Mullen; Simon J Rhodes
Journal:  Mol Endocrinol       Date:  2013-10-07

7.  The forkhead transcription factor, Foxd1, is necessary for pituitary luteinizing hormone expression in mice.

Authors:  Jason H Gumbel; Elizabeth M Patterson; Sarah A Owusu; Brock E Kabat; Deborah O Jung; Jasmine Simmons; Torin Hopkins; Buffy S Ellsworth
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.